儿童炎症性肠病患者中IL-10中和性自身抗体的研究
这项多中心横断面研究在四个国家的儿童炎症性肠病(IBD)队列中检测抗IL-10自身抗体,发现2.5%(26/1045)阳性,且与难治性疾病、急性重症溃疡性结肠炎和结肠切除率升高相关;
要点
- 儿童IBD中抗IL-10自身抗体阳性率为2.5%,以溃疡性结肠炎为主。
- 阳性患者难治性疾病、急性重症UC和结肠切除率均显著高于匹配对照。
核心结论
- 抗IL-10自身抗体存在于部分儿童IBD患者中,并与难治性疾病相关。
研究设计与样本
- 横断面多中心研究,纳入四个国家的儿童IBD队列,共1045例患者,平均发病年龄11.2±3.8岁。
主要发现
- 抗IL-10阳性患者26/1045(2.5%),其中克罗恩病6例、溃疡性结肠炎19例、未分类IBD1例,诊断年龄13±3岁。
- 抗IL-10抗体为IgG类,体外可放大促炎细胞因子应答。
- 阳性患者难治性疾病比例23% vs 6%(p=0.03),急性重症UC比例26% vs 6%(p=0.038),结肠切除率27% vs 6%(p=0.01)。
临床怎么用
- 对儿童IBD患者检测抗IL-10自身抗体可能有助于识别难治性疾病高风险人群。
- HLA-DRB1*01:03检测可作为抗IL-10阳性的遗传标志物参考。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Interleukin-10 (IL-10) is an essential regulator of intestinal immune homeostasis. Neutralising autoantibodies against IL-10 (anti-IL-10) have been identified in children and also adult patients with IBD. Positivity for anti-IL-10 autoantibodies was associated with carriage of HLA-DRB1*01:03 allele. OBJECTIVE: To determine the prevalence of anti-IL-10 in paediatric IBD and assess the associated clinical phenotype. DESIGN: We conducted a cross-sectional multicentre study across paediatric IBD cohorts from four countries. Anti-IL-10 antibodies were investigated in serum and plasma from paediatric patients with IBD (mean age of IBD onset 11.2±3.8 years). IL-10-neutralisation capacity was confirmed by functional IL-10 reporter assay, competitive ELISA and cytokine release assay. Clinical data were analysed to evaluate disease phenotype and treatment outcomes, with comparison with matched controls. HLA-DRB1*01:03 analysis was performed. RESULTS: Anti-IL-10 positivity was identified in 26/1045 paediatric patients with IBD (2.5%) (Crohn's disease n=6, UC n=19, IBD unclassified n=1; IBD diagnosis age of 13±3 years). Anti-IL-10 autoantibodies were of the IgG class and amplified pro-inflammatory cytokine responses in vitro. Anti-IL-10-positive patients exhibited more severe disease compared with matched controls, including an increased prevalence of difficult-to-treat disease (23% vs 6%, p=0.03), higher rate of acute severe UC (26% vs 6%; p=0.038) and higher rates of colectomy (27% vs 6%, p=0.01). Eighty percent (16/20) of anti-IL-10-positive patients with available HLA data carried the HLA-DRB1*01:03 allele, compared with 1.5% in the anti-IL-10-negative group. CONCLUSION: Anti-IL-10 autoantibodies are present in a subgroup of paediatric patients with IBD and are associated with difficult-to-treat disease.
引用
- Gharahdaghi N, Yeh PJ, Vadakethala K, et al. Neutralising autoantibodies against IL-10 and HLA-DRB1*01:03 in paediatric patients with inflammatory bowel disease. Gut. 2026. PMID: 42580871. doi:10.1136/gutjnl-2026-339329
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。